🇺🇸 FDA
Patent

US 10253039

Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

granted A61KA61K31/40A61K31/4025

Quick answer

US patent 10253039 (Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria) held by The Regents of the University of California expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/40, A61K31/4025, A61K31/4155, A61K31/4178